The firm is a European venture capital firm that invests in innovative healthcare and health technology companies addressing large global markets. Operating through a distributed team across multiple European countries, the firm primarily invests in European businesses. The firm typically participates in Seed and Series A financings and can invest up to approximately €5M per company over the life of an investment, including follow-on capital. The firm focuses on companies that have already demonstrated early commercial validation through initial revenues, customer adoption, or market traction. The firm takes an active role in helping portfolio companies scale internationally and build sustainable healthcare businesses.
The firm focuses on healthcare and health technology companies with scalable business models and global market potential. While historically active across therapeutics, medical devices, diagnostics, and digital health, the firm now places greater emphasis on healthtech and B2B healthcare solutions. Key areas of interest include brain health, mental health, women’s health, digital therapeutics, healthcare software, diagnostics, patient engagement platforms, and technologies that improve the efficiency, accessibility, and delivery of healthcare. The firm generally favors companies with commercialized products, established customer demand, and clear pathways to scalable revenue growth.
From a company and management team perspective, the firm seeks ambitious founders developing differentiated solutions to significant healthcare challenges. While the firm does not maintain strict requirements regarding management team composition or prior entrepreneurial experience, it places significant value on execution capability, market understanding, and international scaling potential. The firm works closely with portfolio companies following investment, providing strategic guidance, industry expertise, and access to a network of operators, investors, and commercial partners. The firm may act as either a lead investor or syndicate participant depending on the opportunity.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment